These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7636426)

  • 1. Consistent GH responses to repeated injection of GH-releasing hexapeptide (GHRP-6) and the non-peptide GH secretagogue, L-692,585.
    Fairhall KM; Mynett A; Smith RG; Robinson IC
    J Endocrinol; 1995 Jun; 145(3):417-26. PubMed ID: 7636426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.
    Fairhall KM; Mynett A; Robinson IC
    J Endocrinol; 1995 Mar; 144(3):555-60. PubMed ID: 7738479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No desensitization of the growth hormone (GH) response between GH-releasing peptide-2 and GH-releasing factor in calves.
    Roh SG; He ML; Matsunaga N; Hidaka S; Hidari H
    J Anim Sci; 1997 Oct; 75(10):2749-53. PubMed ID: 9331880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of growth hormone (GH)-releasing hexapeptide (GHRP-6) and GH-releasing factor (GRF) on GH secretion from cultured porcine somatotropes.
    Sánchez-Hormigo A; Castaño JP; Torronteras R; Malagón MM; Ramírez JL; Gracia-Navarro F
    Life Sci; 1998; 63(23):2079-88. PubMed ID: 9839531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a growth hormone-releasing Peptide and growth hormone-releasing factor in conscious and anaesthetized rats.
    Clark RG; Carlsson LM; Trojnar J; Robinson IC
    J Neuroendocrinol; 1989 Aug; 1(4):249-55. PubMed ID: 19210437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central actions of peptide and non-peptide growth hormone secretagogues in the rat.
    Dickson SL; Leng G; Dyball RE; Smith RG
    Neuroendocrinology; 1995 Jan; 61(1):36-43. PubMed ID: 7731496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.
    Cheng K; Chan WW; Butler B; Wei L; Schoen WR; Wyvratt MJ; Fisher MH; Smith RG
    Endocrinology; 1993 Jun; 132(6):2729-31. PubMed ID: 8389289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.
    Wu D; Chen C; Zhang J; Bowers CY; Clarke IJ
    J Endocrinol; 1996 Feb; 148(2):197-205. PubMed ID: 8699133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of L-692,429-stimulated rat growth hormone release by a weak substance P antagonist: L-756,867.
    Cheng K; Wei L; Chaung LY; Chan WW; Butler B; Smith RG
    J Endocrinol; 1997 Jan; 152(1):155-8. PubMed ID: 9014851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel non-peptidyl growth hormone secretagogue.
    Cheng K; Chan WW; Butler B; Wei L; Smith RG
    Horm Res; 1993; 40(1-3):109-15. PubMed ID: 7905455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
    Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
    Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles.
    Jacks T; Hickey G; Judith F; Taylor J; Chen H; Krupa D; Feeney W; Schoen W; Ok D; Fisher M
    J Endocrinol; 1994 Nov; 143(2):399-406. PubMed ID: 7830002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.
    Bowers CY; Reynolds GA; Durham D; Barrera CM; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1990 Apr; 70(4):975-82. PubMed ID: 2108187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.
    Badger TM; Millard WJ; McCormick GF; Bowers CY; Martin JB
    Endocrinology; 1984 Oct; 115(4):1432-8. PubMed ID: 6148232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585.
    Hickey GJ; Drisko J; Faidley T; Chang C; Anderson LL; Nicolich S; McGuire L; Rickes E; Krupa D; Feeney W; Friscino B; Cunningham P; Frazier E; Chen H; Laroque P; Smith RG
    J Endocrinol; 1996 Feb; 148(2):371-80. PubMed ID: 8699151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
    Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.